Schedule 13G ownership disclosure
Immunic Inc
Common Stock, par value $0.0001 per share · CUSIP: 4525EP101
Event date: 2025-08-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 683 CAPITAL MANAGEMENT, LLC
Shares: 10,634,446.00 · Class: 9.9%
- 683 CAPITAL PARTNERS, LP
Shares: 10,634,446.00 · Class: 9.9%
- Zweiman Ari
Shares: 10,634,446.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-002136
- Form type
- SCHEDULE 13G
- Filer
- 683 Capital Management, LLC
- CIK
- CIK 1404574
- Filed
- Aug 08, 2025
- Reporting period
- Aug 02, 2025
- Description
- Schedule 13G beneficial ownership